AZORA THERAPEUTICS
Azora Therapeutics develops therapeutic medicines to treat serious, debilitating inflammatory diseases. It specializes in developing novel small-molecule chemical entities for the treatment of autoimmune and inflammatory diseases like hidradenitis suppurativa (HS) and ulcerative colitis (UC).
AZORA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2017-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.azoratherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
8.32 M USD
Technology used in webpage:
Google Google Cloud Wix
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
AndHealth
AndHealth helps people reverse chronic diseases.
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
Bened Life
Bened Life specializes in the sale of brain medical probiotics.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Juniper Therapeutics
Juniper Therapeutics specializes in treating osteoarthritis.
Revivo Therapeutics
Revivo Therapeutics is specializing in treating brain diseases.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.azoratherapeutics.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Azora Therapeutics"
Azora Therapeutics - Crunchbase Company Profile
Azora Therapeutics develops therapeutic medicines to treat serious, debilitating inflammatory diseases. It specializes in developing novel small-molecule …See details»
Azora Therapeutics - LinkedIn
Azoratherapeutics.com 10 Like Comment Share Join now to see what you are missing Find people you know at Azora Therapeutics Browse recommended jobs for you View all updates, news, and articles ...See details»
AZORA THERAPEUTICS, INC. Company Profile - Dun & Bradstreet
AZORA THERAPEUTICS, INC. Company Profile | Encino, CA | Competitors, Financials & Contacts - Dun & BradstreetSee details»
Azora Therapeutics, Inc. - Drug pipelines, Patents, …
Www.azoratherapeutics.com. Last update 06 Mar 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. ... The statistics for drugs in the Pipeline is the current organization …See details»
Azora Therapeutics Company Profile | Management and
Www.azoratherapeutics.com . Azora Therapeutics Profile and History. Azora Therapeutics is a pharmaceutical development company developing novel therapies for serious autoinflammitory …See details»
Azora Therapeutics: Contact Details and Business Profile
Azoratherapeutics.com; gmail.com; hotmail.com; 5+ 510409XXXX; 310470XXXX; 310477XXXX; 650780XXXX; 310876XXXX; 760983XXXX; View Similar People. Related Companies Spidey …See details»
Azora Therapeutics - LifeScienceHistory.com
Www.azoratherapeutics.com. 4267 Valley Meadow Road. Los Angeles, CA 90291. Company Info Year Established 2017. Contacts Matt Davidson, PhD Co-Founder & CEO Julie Saiki, PhD Co …See details»
Azora Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Azora Therapeutics, Inc.:Company Profile & Technical Research ...
Azora Therapeutics, Inc. is a company that provides Small molecule, Biopharmaceutical and more. Azora Therapeutics, Inc. is headquartered in United States California.See details»
AT-193 for Hidradenitis Suppurativa - Azora Therapeutics
The Hidradenitis Suppurativa Foundation is a non-profit organization improving the lives of people affected by HS through advocacy, education and research. The goals of the Canadian HS …See details»
News - Azora Therapeutics
Dec 30, 2021 Azora Therapeutics Enrolls First Patient in Clinical Trial of AT-193, a Potential Treatment for Hidradenitis Suppurativa Los Angeles CA - October 19, 2021 - Azora …See details»
Azora Therapeutics - PitchBook
Azora Therapeutics General Information Description. Developer of a therapeutic medicine intended to treat serious, debilitating inflammatory diseases. The company specializes in …See details»
Azora Therapeutics - Overview, News & Similar companies
Azora Therapeutics contact info: Phone number: (818) 276-6726 Website: www.azoratherapeutics.com What does Azora Therapeutics do? Azora Therapeutics is a …See details»
Azora Therapeutics - VentureRadar
Develops treatments for serious inflammatory diseases using oral and topical agonists of the aryl hydrocarbon receptor to rebalance immune response mechanisms. "See details»
Azora Therapeutics on LinkedIn: News | Azora Therapeutics
Azora Therapeutics Announces the Publication of Positive Phase 1b Study Results in Treatment-Refractory Ulcerative Colitis! Azora's 1st generation oral AhR…See details»
Science - Azora Therapeutics
Dec 1, 2021 Saiki JP, Andreasson JO, Grimes KV, Frumkin LR, Sanjines E, Davidson MG, Park KT, Limketkai B. Treatment-refractory ulcerative colitis responsive to indigo naturalis ...See details»
Azora Therapeutics, Inc. (Azora Therapeutics, Inc.) - 药物管线_专 …
了解Azora Therapeutics, Inc. (Azora Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1篇新闻和1篇文献，疾病领域:免疫系统疾病，感染，技术平台:小分子化药，药 …See details»
New study results reinforce TAGRISSO® (osimertinib) as the …
Mar 25, 2025 New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca’s TAGRISSO ® (osimertinib), as …See details»
UC Trial | Azora Therapeutics
If you have moderate to severe ulcerative colitis (UC) and you live in the Los Angeles area, you may be eligible to participate in a new clinical trial looking at the safety, tolerability, …See details»
Theratechnologies Receives FDA Approval for EGRIFTA WR™
Mar 25, 2025 EGRIFTA WR™ will be manufactured at a new, U.S.-based contract drug manufacturing organization (CDMO). The new formulation, which is patent protected in the …See details»